I've tested everything from TVs to phones, PCs, tablets and more. Despite the increasingly mobile world we live in, the home printer remains an indispensable tool that will never become truly obsolete ...

Germany’s Affimed has signed a deal with Roche’s Genentech unit to develop cancer immunotherapies that activate natural killer cells, in a deal potentially worth more than $5 billion. The first wave ...